LRRK2 and acute pancreatitis: Blockade of LRRK2-mediated signaling pathways by its specific inhibitor attenuated the development of acute pancreatitis and reduced pancreatic accumulation of T cells, macrophages, and DCs, which effects were accompanied by diminished pancreatic production of proinflammatory cytokines such as IL-6 and TNF-α.